Occudo Quantitative Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $452K | Buy |
+184,658
| New | +$452K | 0.05% | 367 |
|
2023
Q3 | – | Sell |
-10,702
| Closed | -$213K | – | 1255 |
|
2023
Q2 | $213K | Sell |
10,702
-12,785
| -54% | -$254K | 0.02% | 837 |
|
2023
Q1 | $402K | Buy |
+23,487
| New | +$402K | 0.04% | 572 |
|
2022
Q4 | – | Sell |
-34,397
| Closed | -$549K | – | 1302 |
|
2022
Q3 | $549K | Buy |
34,397
+16,483
| +92% | +$263K | 0.04% | 628 |
|
2022
Q2 | $246K | Sell |
17,914
-3,433
| -16% | -$47.1K | 0.02% | 849 |
|
2022
Q1 | $339K | Buy |
21,347
+7,921
| +59% | +$126K | 0.03% | 777 |
|
2021
Q4 | $293K | Buy |
13,426
+259
| +2% | +$5.65K | 0.03% | 777 |
|
2021
Q3 | $394K | Buy |
13,167
+2,522
| +24% | +$75.5K | 0.05% | 627 |
|
2021
Q2 | $471K | Buy |
10,645
+1,909
| +22% | +$84.5K | 0.07% | 448 |
|
2021
Q1 | $388K | Buy |
+8,736
| New | +$388K | 0.08% | 415 |
|